The Vita Coco Company Reports Third Quarter 2026 Financial Results and Raises Full Year Guidance

Vita Coco reported Q3 2026 net sales of $244 million, up 34% year over year, with organic net sales growth of 18%; net income rose $11 million to $35 million and adjusted EBITDA increased $21 million to $53 million. The company raised fiscal 2026 guidance to net sales of $810–$820 million and adjusted EBITDA of $170–$175 million.

Analysis

The key signal is not headline growth alone but whether it is repeatable: organic growth of 18% is materially below reported growth of 34%, so investors should verify how much of the gap reflects acquisitions, pricing, or other non-organic effects before extrapolating the top line. If comparable, growth outside the flagship coconut-water line may be broadening the platform; if not, the portfolio remains more concentrated than the headline suggests.

The EBITDA increase alongside slower organic growth suggests favorable operating leverage, but one quarter does not establish a durable margin profile. Watch whether higher costs for coconut inputs, packaging, freight, or promotional support absorb that leverage. The raised outlook provides near-term support, yet without the prior guide and consensus estimates it is not possible to judge the size of the surprise or how much is already reflected in COCO’s valuation.

Over 1–3 months, the main catalyst is evidence that organic growth and EBITDA conversion persist through the holiday quarter. Over 6–18 months, distribution gains and repeat purchases matter more than reported growth; larger beverage groups and private-label offerings can pressure shelf space and pricing. The contrarian risk is that the market capitalizes the reported growth rate as though it were organic and recurring.

Key Decisions for Investors

• Maintain a positive but valuation-sensitive bias on COCO; do not chase a gap-up without checking the stock’s reaction against the prior close and whether the raised outlook exceeds existing expectations. No price target is supportable from the supplied information.
• For a 1–3 month add, wait for the next reporting or channel-check evidence on organic sales, repeat purchase, and promotional intensity. Falsify the constructive view if organic growth decelerates materially or EBITDA conversion reverses despite continued sales growth.
• Track the reported-versus-organic growth bridge and the exact components of the guidance change. If non-organic contributions explain much of the growth or the guide raise is small relative to expectations, treat the headline as lower-quality momentum rather than a new earnings trajectory.
• Monitor coconut-input, packaging, and freight costs, plus shelf-space and pricing activity from large beverage competitors and private label. These are potential margin and share risks, not impacts established by this release.